Article

MS Survival and Comorbidities

Autoimmune process alone not sole determinant


 

References

Multiple sclerosis (MS) survival is influenced not only by the underlying autoimmune process, but also by patient comorbidities and lifestyle factors, according to a retrospective analysis of 1,713 MS patients in the UK Clinical Practice Research Datalink.

Investigators followed patients to identify deaths and causes and found infections and depression are common comorbidities at 80% and 46%, respectively. In addition, the adjusted hazard ratios for all-cause mortality were:

•current smoking: 2.0

•alcohol abuse: 7.6

•pneumonia and influenza: 2.7

•urinary tract infections: 4.1

•heart disease, 2.2

•cancer: 4.9

Citation: Jick SS, Li L, Falcone GJ, Vassilev ZP, Wallander MA. Epidemiology of multiple sclerosis: results from a large observational study in the UK. J Neurol. 2015. [Epub ahead of print]

Recommended Reading

New drugs saw ‘unprecedented’ spending growth in 2014
MDedge Neurology
Cervical Cord Atrophy in CIS and RRMS
MDedge Neurology
Weight in Adolescence Correlates to Age of MS Diagnosis
MDedge Neurology
Information Processing Differs by Age of MS Diagnosis
MDedge Neurology
Depression, Anxiety, and Multiple Sclerosis
MDedge Neurology
Can MS Progression be Predicted?
MDedge Neurology
Only moderate-quality evidence supports medical cannabinoids
MDedge Neurology
Adherence to MS treatments lower in oral vs. injectable drugs
MDedge Neurology
Optimizing treatment selection in MS often tricky
MDedge Neurology
Abundance of agents adds choice in choosing MS therapy
MDedge Neurology